Bristol-Myers Squibb Other Income (Expense) increased by 121.9% to $108.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 146.2%, from -$234.00M to $108.00M.
Significant fluctuations often relate to changes in interest rates, investment valuations, or currency volatility.
The net total of income and expenses from non-operating activities, such as interest income, interest expense, and gains...
Companies with large cash piles often show significant interest income here, while highly levered firms show interest expense.
is_other_income_expense_net| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.00M | $409.00M | -$649.00M | -$284.00M | $140.00M | $413.00M | $116.00M | $258.00M | $371.00M | -$81.00M | -$273.00M | -$234.00M | -$305.00M | -$339.00M | -$494.00M | $108.00M |
| QoQ Change | — | >999% | -258.7% | +56.2% | +149.3% | +195.0% | -71.9% | +122.4% | +43.8% | -121.8% | -237.0% | +14.3% | -30.3% | -11.1% | -45.7% | +121.9% |
| YoY Change | — | — | — | <-999% | -65.8% | +163.6% | +140.8% | +84.3% | — | -119.6% | -335.3% | -190.7% | -182.2% | -318.5% | -81.0% | +146.2% |